RSS

Ian Bolland

With the UK general election on the horizon, what are the implications for pharma and life sciences. Read more

Opinion

A research report from Owen Mumford Pharmaceutical Services estimates market opportunities for emerging biosimilar markets. Read more

News

The UK will need to establish its own systems in parallel with that of the European Union for life sciences in the event of a No Deal Brexit, according to a report from the House of Commons Exiting the EU Committee. Read more

News

New regulations have been unveiled by the pharmacy regulator the General Pharmaceutical Council for the purchasing of medicines online. Read more

News

A survey for The Independent Pharmacy suggests that 83% of the population do not know how to check if a medicine they have purchased online is legitimate. Read more

News

The Topol Review has been launched outlining a vision of a digital future for the NHS using the latest technologies across the themes of genomics, digital medicine, and AI and robotics. Read more

News

Assistant editor Ian Bolland explains how a genomics-based personalised risk assessment is aiming to improve screening programmes for breast cancer. Read more

News

Pharmaceutical company Otsuka America and software treatment firm Click Therapeutics have reached a collaboration agreement to develop and commercialise a prescription digital therapeutic treatment for Major Depressive Disorder (MDD). Read more

News